The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients': a retrospective, multi-centric cohort study.
Mohammadreza SalehiMahdi Barkhori MehniMohammadmehdi AkbarianSamrand Fattah GhaziNasim Khajavi RadOmid Moradi MoghaddamSaeedReza Jamali MoghaddamMasoumeh Hosseinzadeh EmamSayed Hamidreza AbtahiMaryam MoradiFereshteh GhiasvandPublished in: European journal of medical research (2022)
Our data indicate that the use of IVIG in critically ill COVID-19 patients could not be beneficial, based on no remarkable differences in duration of hospitalization, ICU length of stay, duration of mechanical ventilation, and even mortality rate.
Keyphrases